Dr. Brian S. Schwartz, MD

Dr. Schwartz practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Schwartz's NPI, 1548228653, was assigned on May 1, 2006. Dr. Schwartz graduated from Rush Medical College in 2001. Dr. Schwartz holds California license A91275.

Dr. Schwartz's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Schwartz's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Dr. Schwartz is also affiliated with UCSF Langley Porter Psychiatric Hospital. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Schwartz to 3 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schwartz practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Schwartz's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Schwartz is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Schwartz's licenses on file in 2 states: California and Massachusetts.

Dmand AI lists joint or bone infection, pneumonia and yeast infection among the conditions Dr. Schwartz treats.

CMS data shows 179 Medicare services from Dr. Schwartz across 7 procedure codes in 2024, for 101 Medicare patients. Medicare paid $15,741 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 101 Medicare patients who saw Dr. Schwartz in 2024. The largest group is 65 to 74, with 36 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 50% are also on Medicaid. Their average risk score is 3.46, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schwartz's median patient age at 60, with 50% women.

In 2024, Dr. Schwartz wrote 180 Medicare Part D claims for 36 patients. 89% of them were for generic drugs. CMS names the drug for 48 of them, across 3 drugs with 11 or more claims each, at $47,652 in total drug cost. In 2023, CMS named 100 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Schwartz for performance year 2024, reported as part of a group. Dr. Schwartz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schwartz as offering telehealth.

Dmand AI links 102 papers to Dr. Schwartz, published from 2005 to 2025. 2021 was the busiest year, with 3. The most frequent topics are Lead, Occupational Exposure and Tibia. Dr. Schwartz has published most often in Environ Health Perspect. Dr. Schwartz's most frequent co-authors are Brian Gabriel Schwartz, MD, Howard Hu, DSC, MD, MPH and Bernard Georges Jaar, MD.

Dmand AI links Dr. Schwartz to 1 clinical trial. Conditions studied include Staphylococcal Infections and Gram-Positive Bacterial Infections.

Dmand AI lists 2 awards for Dr. Schwartz, most recently CMS Stage 1 EHR in 2013.

Dr. Schwartz graduated from Rush Medical College in 2001.

Dr. Schwartz is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.